AcouSort AB (publ) (STO:ACOU)
2.880
-0.320 (-10.00%)
Sep 4, 2026, 11:48 AM CET
AcouSort AB Revenue
AcouSort AB had revenue of 2.14M SEK in the quarter ending June 30, 2026, a decrease of -25.62%. This brings the company's revenue in the last twelve months to 9.31M, down -11.90% year-over-year. In the year 2025, AcouSort AB had annual revenue of 10.43M with 4.01% growth.
Revenue (ttm)
9.31M
Revenue Growth
-11.90%
P/S Ratio
7.27
Revenue / Employee
846.73K
Employees
11
Market Cap
67.72M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.43M | 402.00K | 4.01% |
| Dec 31, 2024 | 10.03M | -521.00K | -4.94% |
| Dec 31, 2023 | 10.55M | 1.97M | 22.90% |
| Dec 31, 2022 | 8.59M | 2.63M | 44.04% |
| Dec 31, 2021 | 5.96M | -863.00K | -12.65% |
| Dec 31, 2020 | 6.82M | 3.78M | 124.37% |
| Dec 31, 2019 | 3.04M | 1.67M | 122.13% |
| Dec 31, 2018 | 1.37M | -1.23M | -47.22% |
| Dec 31, 2017 | 2.59M | -128.00K | -4.70% |
| Dec 31, 2016 | 2.72M | 1.15M | 72.83% |
| Dec 31, 2015 | 1.58M | -310.00K | -16.45% |
| Dec 31, 2014 | 1.89M | 308.63K | 19.58% |
| Dec 31, 2013 | 1.58M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 136.17M |
| Fluicell AB | 22.19M |
| Biovica International AB | 13.49M |
| OncoZenge AB | 5.97M |
| Spago Nanomedical AB | 3.81M |
| Simris Group AB (PUBL) | 1.39M |
| Pila Pharma AB | 275.74K |
AcouSort AB News
- 9 days ago - AcouSort AB Quarterly report: Q2 2026 - Filings
- 3 months ago - AcouSort AB Quarterly report: Q1 2026 - Filings
- 6 months ago - AcouSort AB Quarterly report: Q4 2025 - Filings
- 6 months ago - AcouSort AB Annual report: Q4 2025 - Filings
- 9 months ago - AcouSort AB Quarterly report: Q3 2025 - Filings